Related Experiment Videos
Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides
V A Boundy1, R R Luedtke, R P Artymyshyn
1Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084.
Molecular Pharmacology
|May 1, 1993
Summary
Researchers developed novel antibodies targeting dopamine D2 receptor isoforms. These antibodies successfully distinguished between D2L and D2S isoforms, aiding in receptor research and understanding dopamine signaling pathways.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Dopamine receptors, particularly subtypes like D2, play crucial roles in neurological functions.
- Existing ligands often lack specificity for individual dopamine receptor subtypes.
- Immunologic methods offer a promising alternative for differentiating receptor subtypes and isoforms.
Purpose of the Study:
- To develop and characterize polyclonal antipeptide antibodies against distinct regions of rat D2 dopamine receptor isoforms.
- To utilize these antibodies to distinguish between D2L and D2S dopamine receptor isoforms.
- To investigate the role of specific intracellular loops in D2 receptor function and signaling.
Main Methods:
- Synthetic peptides corresponding to unique and shared portions of the third intracellular loops of D2L and D2S isoforms were synthesized.
- Polyclonal antipeptide antibodies were generated in rabbits via immunization.
- Immunogenicity was confirmed using radioimmunoassay; antibody specificity and receptor recognition were assessed via immunoprecipitation assays using radiolabeled antagonist (125I-NCQ 298) and transfected cell lines.
- Immunoblotting and immunohistochemistry were employed to analyze receptor distribution and identify specific protein bands.
Main Results:
- Both immunogens successfully elicited high-titer antipeptide antibodies.
- Antisera to D2-284 quantitatively immunoprecipitated D2 receptors from rat and canine striatal extracts, while antisera to D2-244 immunoprecipitated 40% of rat caudate D2 receptors.
- Antisera to D2-284 recognized both D2L and D2S isoforms, whereas antisera to D2-244 were specific for the D2L isoform.
- Immunohistochemistry revealed widespread D2 receptor distribution in rat brain, particularly in the striatum.
- Anti-D2-284 antisera disrupted agonist binding, suggesting the involvement of the D2-284 peptide region in G-protein coupling.
Conclusions:
- Novel antipeptide antibodies provide a valuable tool for distinguishing between D2 dopamine receptor isoforms.
- The third intracellular loop, particularly the region represented by D2-284, is implicated in D2 receptor-guanine nucleotide-binding protein coupling.
- These findings advance the understanding of D2 receptor heterogeneity and function in the central nervous system.